Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, Status and Forecast 2021-2027

Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Avanafil
1.2.5 Vardenafil
1.3 Market by Application
1.3.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Perspective (2016-2027)
2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Trends by Regions
2.2.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Share by Regions (2016-2021)
2.2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Regions (2022-2027)
2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Dynamic
2.3.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Trends
2.3.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
2.3.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
2.3.4 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Revenue
3.1.1 Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Revenue (2016-2021)
3.1.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Players (2016-2021)
3.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue
3.4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio
3.4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2020
3.5 Phosphodiesterase Type 5 (PDE5) Inhibitor Key Players Head office and Area Served
3.6 Key Players Phosphodiesterase Type 5 (PDE5) Inhibitor Product Solution and Service
3.7 Date of Enter into Phosphodiesterase Type 5 (PDE5) Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Type
4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Type (2016-2021)
4.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (2022-2027)
5 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Application
5.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Application (2016-2021)
5.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2016-2027)
6.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
6.2.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2021)
6.2.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2022-2027)
6.2.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2027)
6.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
6.3.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2021)
6.3.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2022-2027)
6.3.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2027)
6.4 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
6.4.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2016-2021)
6.4.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2016-2027)
7.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
7.2.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2021)
7.2.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2022-2027)
7.2.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2027)
7.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
7.3.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2021)
7.3.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2022-2027)
7.3.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2027)
7.4 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
7.4.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2016-2021)
7.4.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2016-2027)
8.2 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
8.2.1 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2027)
8.3 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
8.3.1 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2027)
8.4 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region
8.4.1 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2016-2027)
9.2 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
9.2.1 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2021)
9.2.2 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2022-2027)
9.2.3 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2027)
9.3 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
9.3.1 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2021)
9.3.2 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2022-2027)
9.3.3 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2027)
9.4 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
9.4.1 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2016-2021)
9.4.2 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2016-2027)
10.2 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
10.2.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2027)
10.3 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
10.3.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2027)
10.4 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
10.4.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.1.4 Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.2.4 Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.3.4 Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.4.4 Novartis AG Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.5.4 Merck Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.5.5 Merck Recent Development
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Company Details
11.6.2 GlaxoSmithKline plc Business Overview
11.6.3 GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.6.4 GlaxoSmithKline plc Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.6.5 GlaxoSmithKline plc Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.7.4 Roche Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.7.5 Roche Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.8.4 AstraZeneca Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 BaiYunShan General Factory
11.9.1 BaiYunShan General Factory Company Details
11.9.2 BaiYunShan General Factory Business Overview
11.9.3 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.9.4 BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.9.5 BaiYunShan General Factory Recent Development
11.10 SK Chemicals
11.10.1 SK Chemicals Company Details
11.10.2 SK Chemicals Business Overview
11.10.3 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.10.4 SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.10.5 SK Chemicals Recent Development
11.11 Teva Pharma
11.11.1 Teva Pharma Company Details
11.11.2 Teva Pharma Business Overview
11.11.3 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.11.4 Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.11.5 Teva Pharma Recent Development
11.12 Dong-A ST
11.12.1 Dong-A ST Company Details
11.12.2 Dong-A ST Business Overview
11.12.3 Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.12.4 Dong-A ST Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.12.5 Dong-A ST Recent Development
11.13 Metuchen Pharma
11.13.1 Metuchen Pharma Company Details
11.13.2 Metuchen Pharma Business Overview
11.13.3 Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.13.4 Metuchen Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.13.5 Metuchen Pharma Recent Development
11.14 Seoul Pharma
11.14.1 Seoul Pharma Company Details
11.14.2 Seoul Pharma Business Overview
11.14.3 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.14.4 Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.14.5 Seoul Pharma Recent Development
11.15 Vectura Group
11.15.1 Vectura Group Company Details
11.15.2 Vectura Group Business Overview
11.15.3 Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.15.4 Vectura Group Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021)
11.15.5 Vectura Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sildenafil
Table 3. Key Players of Tadalafil
Table 4. Key Players of Avanafil
Table 5. Key Players of Vardenafil
Table 6. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Regions (2016-2021)
Table 10. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Regions (2022-2027)
Table 12. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Trends
Table 13. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
Table 14. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
Table 15. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
Table 16. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Players (2016-2021)
Table 18. Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor as of 2020)
Table 19. Ranking of Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Phosphodiesterase Type 5 (PDE5) Inhibitor Product Solution and Service
Table 23. Date of Enter into Phosphodiesterase Type 5 (PDE5) Inhibitor Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2016-2021)
Table 27. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Application (2016-2021)
Table 31. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 66. Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 67. Eli Lilly Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 71. Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Bayer Company Details
Table 74. Bayer Business Overview
Table 75. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 76. Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 77. Bayer Recent Development
Table 78. Novartis AG Company Details
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 81. Novartis AG Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 82. Novartis AG Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 86. Merck Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. GlaxoSmithKline plc Company Details
Table 89. GlaxoSmithKline plc Business Overview
Table 90. GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 91. GlaxoSmithKline plc Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 92. GlaxoSmithKline plc Recent Development
Table 93. Roche Company Details
Table 94. Roche Business Overview
Table 95. Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 96. Roche Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 97. Roche Recent Development
Table 98. AstraZeneca Company Details
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 101. AstraZeneca Recent Development
Table 102. BaiYunShan General Factory Company Details
Table 103. BaiYunShan General Factory Business Overview
Table 104. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 105. BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 106. BaiYunShan General Factory Recent Development
Table 107. SK Chemicals Company Details
Table 108. SK Chemicals Business Overview
Table 109. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 110. SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 111. SK Chemicals Recent Development
Table 112. Teva Pharma Company Details
Table 113. Teva Pharma Business Overview
Table 114. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 115. Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 116. Teva Pharma Recent Development
Table 117. Dong-A ST Company Details
Table 118. Dong-A ST Business Overview
Table 119. Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 120. Dong-A ST Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 121. Dong-A ST Recent Development
Table 122. Metuchen Pharma Company Details
Table 123. Metuchen Pharma Business Overview
Table 124. Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 125. Metuchen Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 126. Metuchen Pharma Recent Development
Table 127. Seoul Pharma Company Details
Table 128. Seoul Pharma Business Overview
Table 129. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 130. Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 131. Seoul Pharma Recent Development
Table 132. Vectura Group Company Details
Table 133. Vectura Group Business Overview
Table 134. Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 135. Vectura Group Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2016-2021) & (US$ Million)
Table 136. Vectura Group Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type: 2020 VS 2027
Figure 2. Sildenafil Features
Figure 3. Tadalafil Features
Figure 4. Avanafil Features
Figure 5. Vardenafil Features
Figure 6. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Other Case Studies
Figure 11. Phosphodiesterase Type 5 (PDE5) Inhibitor Report Years Considered
Figure 12. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Regions: 2020 VS 2027
Figure 15. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Regions (2022-2027)
Figure 16. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Players in 2020
Figure 17. Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2020
Figure 19. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2016-2021)
Figure 20. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2022-2027)
Figure 21. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2016-2027)
Figure 23. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2016-2027)
Figure 24. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2016-2027)
Figure 25. United States Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2016-2027)
Figure 29. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2016-2027)
Figure 30. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2016-2027)
Figure 31. Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2016-2027)
Figure 41. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2016-2027)
Figure 49. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2016-2027)
Figure 50. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2016-2027)
Figure 51. Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2016-2027

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs